[go: up one dir, main page]

TW552127B - A device and a method for non-invasively measuring the blood pressure - Google Patents

A device and a method for non-invasively measuring the blood pressure Download PDF

Info

Publication number
TW552127B
TW552127B TW91109947A TW91109947A TW552127B TW 552127 B TW552127 B TW 552127B TW 91109947 A TW91109947 A TW 91109947A TW 91109947 A TW91109947 A TW 91109947A TW 552127 B TW552127 B TW 552127B
Authority
TW
Taiwan
Prior art keywords
blood pressure
systolic
measurement
condition
diastolic blood
Prior art date
Application number
TW91109947A
Other languages
Chinese (zh)
Inventor
Klaus Forstner
Original Assignee
Microlife Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microlife Corp filed Critical Microlife Corp
Application granted granted Critical
Publication of TW552127B publication Critical patent/TW552127B/en

Links

Landscapes

  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

By a method to measure the blood pressure of a patient, a series of measurements for the diastolic, the systolic blood pressure and for the pulse rate are made. The results are analyzed in order to determine, and to display whether the patient is properly settled to a rest condition, and whether the patients blood pressure variation is found as being normal. Further it is investigated, whether there are high measurement result alterations due to artifacts. Highly altered results are excluded. If the results are sufficiently similar, an average of the result is made. If the results are not sufficiently similar, but still below pre-defined alteration limits, a weighted average is applied to the systolic and the diastolic blood pressure.

Description

552127 A7 ^ -~---B7_______ 五、發明說:ΓΤ ~ 本發明係關於一種以非侵入式測量病人血壓之方法及 其裝置。以非侵入式測量病人血壓之自動電子血壓計,乃 廣為人們所知。此種血壓計基本上可用振動示波量測之類 的’則星法’以量測收縮壓與舒張壓之血壓值。在量測時, 疋依據病人的臂式環帶在充氣放氣時所形成的壓力值。因 此,基本上可依環帶壓力的變化,測得心臟收縮與心臟舒 張壓,甚至是脈搏跳動率。 自動電子血壓測量裝置通常套在病人的上臂,手腕或 手指上。在量測時,總是會有某些特別的原因而導致誤差 。然而會造成測量結果之不準確可能是因為病人正常的生 理變化、未充分的靜心狀態、病理性血壓變化,抑或與贗 值相關的技術或使用問題。例如,量測時的位置變動可能 會造成使用性贗值。若病人正確地遵循此測量裝置之使用 說明書,則可避免因未充分靜心狀態及晃動性贗值所導致 的誤差。一般而言,在量測時,只要病人未處於充分靜心 之狀態,或者病人位置晃動,都將可能導致不正確之測量 結果。 此問題已於同時提出申請之本發明人歐洲專利申請 ΕΡ-99122743. 9號案中加以闡述。 本發明之目的係克服前技之缺失,特別係提供一種自 動、非侵入式血壓計,以及一種用於測量血壓之方法,以 減少此種非正確之測量結果。此外,本發明之又一目的係 檢測血壓量測時生理性血壓變化。 依據本發明,為解決上述之目的,而採用依據本文申 (請先閱讀背面之注意事項再填寫本頁) -------訂·IL------線 4 五、發明說明() 請專利範圍諸獨立項之方法及其以非侵入式測量血壓之裝 置。 然而,我們發現,會導致前後不同血壓值之量測結果 ,主要有四個原因。其為病人正常的生理變化,未充分的 靜〜狀態,抑或病理性企壓變化。然而,病理變化可能是 源於種種心血官失調所致。冑後,其變化亦彳能源於屑值 。今觀察到的有技術性贗值,諸如裝置造成之干擾,以及 使用性贗值,諸如病人晃動造成之干擾。 關於相繼的量測結果之間每一種差值的原因,其各有 特定之機率。 出現無特定傾向之輕度差異,主要係緣於動脈血壓之 生理性變化。所謂的中輕度差異,乃為熟悉該業之人士所 知的遵循特定㈣變化之規律,其可㈣病人靜心狀況不 :之情況而定。通常而言’於此情況下,心臟舒張壓之測 =結果會依次上升’細縮壓與搏_率值會依次下 就我們所知,不同的病理性血壓失調會導致中等程戶 之變化° ^而,高程度之變化則大多緣於層值。 本發明得以提高對血壓測量結果之判斷力。特 本發明得以將频所造成之誤差,與⑽與/或生理^ 化所造成之誤差純分區。此外,本發明得 = 否放鬆至靜心狀態。 疋病人疋 以非侵入式測量 尤宜以示波計測 依據本發明之方法,於第一步驟中, 病人之心臟舒張與收縮壓值以及搏動率,552127 A7 ^-~ --- B7_______ 5. Invention: ΓΤ ~ The present invention relates to a method and device for non-invasively measuring a patient's blood pressure. Automatic electronic sphygmomanometers for non-invasively measuring a patient's blood pressure are widely known. This type of sphygmomanometer can basically measure the blood pressure values of systolic and diastolic blood pressure using a 'star method' such as vibration oscillometric measurement. During the measurement, 疋 is based on the pressure formed by the patient's armband during inflation and deflation. Therefore, it is basically possible to measure the systolic and diastolic blood pressure, and even the pulse beat rate according to the change in the pressure of the cuff. Automatic electronic blood pressure measurement devices are usually placed on the patient's upper arm, wrist or finger. When measuring, there are always some special reasons that cause errors. However, the inaccuracy of the measurement results may be due to the patient's normal physiological changes, inadequate meditation status, pathological blood pressure changes, or technical or usage problems related to threshold values. For example, positional changes during measurement may cause usability thresholds. If the patient follows the instruction manual of the measuring device correctly, errors caused by insufficient meditation and shaking threshold can be avoided. Generally speaking, as long as the patient is not in a state of sufficient meditation or the patient's position is shaking during the measurement, incorrect measurement results may be caused. This problem has been explained in the European patent application EP-99122743. 9 filed by the inventor at the same time. The purpose of the present invention is to overcome the lack of prior art, and in particular to provide an automatic, non-invasive sphygmomanometer and a method for measuring blood pressure to reduce such incorrect measurement results. In addition, another object of the present invention is to detect physiological blood pressure changes during blood pressure measurement. According to the present invention, in order to solve the above-mentioned purpose, the application based on this article is adopted (please read the precautions on the back before filling this page) ------- Order · IL ------ line 4 5. Description of the invention () The method of independent items of patent scope and the device for non-invasively measuring blood pressure. However, we found that there are four main reasons for the different blood pressure measurements before and after. It is a patient's normal physiological changes, inadequate static state, or pathological changes in stress. However, the pathological changes may be caused by various disorders of heart and blood organs. After that, its change is also affected by the chip value. Technical thresholds observed today, such as interference caused by the device, and usage thresholds, such as interference caused by patient shaking. Regarding the cause of each difference between successive measurement results, each has a specific probability. The slight difference without specific tendency is mainly due to the physiological changes in arterial blood pressure. The so-called mild-to-moderate differences are known to those who are familiar with the industry and follow specific rules of change, which may vary depending on the patient's meditation status. Generally speaking, 'In this case, the measurement of diastolic blood pressure = the result will rise in turn.' ^ Much of the high degree of change is due to layer values. The invention can improve the judgment of blood pressure measurement results. The present invention makes it possible to purely partition the error caused by frequency and the error caused by noise and / or physiology. In addition, the present invention has to = no relax to a meditation state.疋 Patient 疋 Non-invasive measurement, especially oscillometric measurement. According to the method of the present invention, in the first step, the patient's diastolic and systolic blood pressure values and pulsation rate,

表紙張尺度刺 297公釐) 552127 A7 ____B7 "~~ ~""""""' -----* 五、發明說明() 量法為之。此示波計測量法已為熟悉該業人士所知,故毋 庸詳細解釋。 於第-步驟a ·)中量測心臟舒張、心臟收縮壓值以 及搏動率之後,將第一步驟a ·)重覆至少一次。藉此, 遂產生心臟收縮與心臟舒張壓以及搏動率之一系列連續的 測量結果。接著對下文所指定之各值,如平均值,進行計 算。 0 於下一步驟中,對此系列之連續結果作自動分析,以 確定該結果之有效性。在分析時,可確認該結果是否滿足 下列條件中一項或多項: 條件i·):確認心臟舒張或心臟收縮壓值以及搏動率 之測量結果是否穩步遞減或遞增。倘若在相繼量測中,心 臟收縮壓值連續遞減,或者心臟舒張壓值連續遞增或遞減 ,且於此同時,搏動率於量測期間連續遞減,則可斷言病 人未處於充分之靜心狀態。 連續之遞減或遞增界定如下,參考三次測量分析:Table paper scale thorn 297 mm) 552127 A7 ____B7 " ~~ ~ " " " " " " '----- * 5. Description of the invention () Quantitative method. This oscilloscope measurement method is known to those familiar with the industry, so it is not necessary to explain it in detail. After measuring diastole, systolic blood pressure value, and pulsatility rate in step-a)), repeat the first step a)) at least once. As a result, a series of continuous measurements of systolic and diastolic blood pressure and pulsatile rate are produced. The values specified below, such as the average, are then calculated. 0 In the next step, the continuous results of this series are automatically analyzed to determine the validity of the results. During the analysis, it can be confirmed whether the result meets one or more of the following conditions: Condition i ·): Confirm whether the measured results of the diastolic or systolic blood pressure value and the pulsation rate are steadily decreasing or increasing. If, in successive measurements, the systolic blood pressure value continuously decreases, or the diastolic blood pressure value continues to increase or decrease, and at the same time, the pulsation rate continuously decreases during the measurement period, it can be concluded that the patient is not in a state of sufficient meditation. The continuous decrease or increase is defined as follows, with reference to three measurements and analysis:

Si-S(i-l)<ASi,i-l (A)Si-S (i-l) < ASi, i-l (A)

Di-D(i-1)<紙 i-1 (Βϊ)Di-D (i-1) < Paper i-1 (Βϊ)

Di-D(i-l)<>ADi,i-1 (B2)Di-D (i-l) < > ADi, i-1 (B2)

Pi-P(i- 1)<ΔΡί,i-l (〇 其中典型的常數為: AS32 =AS21 = -5[mmHg] △D32 =AD21 = -3[mmHg]或者+3[mmHg] ΔΡ32 = -3[bpm] 6 木紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂· -線 552127 A7 五、發明說明( ΔΡ21 = -5[bpm] 若(A)與(B1)與(C)或者(A)與(B2)與⑹成 )成立。 立 則條件 條件ii, 張壓、心臟收縮壓以及搏動率==11果該 量分別按下列公式求出 =丄 Α - mean n mean n Σ 其中mean =之 R.Pi-P (i- 1) < ΔΡί, il (〇 where the typical constants are: AS32 = AS21 = -5 [mmHg] △ D32 = AD21 = -3 [mmHg] or +3 [mmHg] ΔΡ32 = -3 [bpm] 6 Wood paper size applies to China National Standard (CNS) A4 (210 X 297 mm) (Please read the precautions on the back before filling this page) Order · -line 552127 A7 V. Description of the invention (ΔΡ21 =- 5 [bpm] If (A) and (B1) and (C) or (A) and (B2) and ⑹ 成) hold true. Condition ii, tension, systolic pressure, and pulsation rate == 11 The quantities are calculated according to the following formulas: 丄 Α-mean n mean n Σ where mean = R.

Ri n n;Σ 丨心-Σ尽丨 n ---I--I I I I--I · I I (請先閱讀背面之注意事項再填寫本頁) 訂.Ri n n; Σ 丨 heart-Σ end 丨 n --- I--I I I I--II I (Please read the precautions on the back before filling this page).

曰式中Ri分別為心臟舒張、心臟收縮壓以及搏動率之 測量結果,而η為連續測量之次數。變量指數之確定,乃 針對心臟收縮、心臟舒張壓以及搏動率之所有數值而言。 該變里私數為一指標,乃描述量測之穩定性。若變量指數 咼,可能是因為心血管失調而影響血壓之穩定性所造成的 ,如源於心律失調、心力衰竭或者動脈控制失調。因此, 可將每一測夏結果之變量指數與一預定或可預定之變量指 數極限相比較。若該變量指數高於此極限,即可以此結果 而告知病人/使用者。建議病人再作一次新的測量。 條件i i i ·):依據本發明另一較佳之實施例,是確定 心臟收縮廢與心臟舒張壓中相繼測量結果間之差值是否低 於一預定的或可預定的相似性極限。該相似性極限諸如可 設定成:對心臟舒張壓為+/- l2mmHg,而對心臟收縮壓為 +/- 18mmHg。倘若該等差值低於相似性極限,則可假定血 木紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 552127 A7 I----—-------— B7__ 五、發明說明() _量結果彼此充分相似°於此情形下,基於心、臟收縮與 心臟舒張敎測量結果,以求出標準算術平均值。 條件1ν·):依據又—較佳之實關,乃為確定心臟收 縮與心臟舒張壓中連續測量結果之差值是否高於一預定的 相異性極限。原則上,該相似性極限值可設定為:對心臟 舒張壓為+/- 25_Hg,而對心臟舒張壓為+/_ 。 右該血[測里結果中有一項低於此極限,即可假設此項結 果殊異’且歸因於独。因此,在測量序列中的這種結果 都被忽略了。 錢量結果,凡高於條件iu所謂之相錄極限但低 =條件iv所謂之相異性極限者,可能是因為病理性心血 管現象所造成1而’也可能是因層值所引起。雖然上述 推論之結論不盡正確,但也不可完全忽略。我們可將測量 結果加權成-平均值,如此可令此些值之影響減小。因此 丨確疋f生之測畺結果其作用不及一般性之測量結果。藉 由此一測量,可降低贗值。 θ I 各測量結果,凡未超出條件iii所謂之相似性極限者 ,可能是正確的測量結果。此被用於計算出標準平均結果 原則上,我們進行三次測量。若有一項測量結果被省 略貝J可進行第四次測量,以產生三個可使用的測量結果 。若假設一贗值為測量裝置以特定之方式所測得,便會出 =一次復測。因此血塵之最大測量次數取5,包括3次測 星 —人了此由贗值引起之復測,以及一次可能由相異性 表紙^度適。χ 297拓------——·In the formula, Ri is the measurement result of diastolic, systolic blood pressure and pulsation rate, and η is the number of continuous measurements. The variable index is determined for all values of systolic, diastolic blood pressure, and pulsatile rate. The private number in this variable is an indicator that describes the stability of the measurement. If the variable index is 咼, it may be due to cardiovascular disorders that affect the stability of blood pressure, such as from arrhythmia, heart failure, or arterial control disorders. Therefore, the variable index of each summer test result can be compared with a predetermined or predeterminable variable index limit. If the variable index is above this limit, the patient / user can be informed of this result. It is recommended that the patient take another measurement. Condition i i i ·): According to another preferred embodiment of the present invention, it is determined whether the difference between successive measurement results of cardiac systolic waste and diastolic blood pressure is lower than a predetermined or predeterminable similarity limit. The similarity limit can be set, for example, to be: +/- 12 mmHg for diastolic blood pressure and +/- 18 mmHg for systolic blood pressure. If these differences are below the similarity limit, it can be assumed that the size of the blood wood paper is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 552127 A7 I -------------------- B7__ 5. Description of the invention () _ The measurement results are sufficiently similar to each other. In this case, based on the measurement results of cardiac, visceral contraction and diastolic 敎, to obtain the standard arithmetic mean. Condition 1v ·): Based on yet another—a better fact, it is to determine whether the difference between consecutive measurements of cardiac contraction and diastolic blood pressure is higher than a predetermined dissimilarity limit. In principle, the similarity limit can be set as follows: diastolic blood pressure to the heart is +/- 25_Hg, and diastolic blood pressure to the heart is + / _. Right this blood [One of the results in the test is below this limit, it can be assumed that this result is unique 'and attributed to independence. Therefore, such results in the measurement sequence are ignored. As a result of money, anyone who is higher than the so-called recording limit of condition iu but low = the so-called disparity limit of condition iv may be caused by pathological cardiovascular phenomena1 and may also be caused by the stratum value. Although the above conclusions are not correct, they cannot be completely ignored. We can weight the measurement results to an average value, which can reduce the impact of these values. Therefore, confirming the results of health tests is not as effective as the results of general measurements. By this measurement, the threshold value can be reduced. Each measurement result of θ I that does not exceed the so-called similarity limit of condition iii may be a correct measurement result. This is used to calculate the standard average result. In principle, we take three measurements. If one measurement result is omitted, J may perform a fourth measurement to produce three usable measurement results. If it is assumed that the value is measured by the measuring device in a specific way, it will be = a retest. Therefore, the maximum number of measurements of blood dust is taken as 5, including 3 measurements-this is a re-measurement caused by the threshold value, and one time may be determined by the degree of difference of the paper. χ 297 Extension ---------- ·

I · I I (請先Μ讀背面之注意事項再填寫本頁) -n n n n <I · I I (Please read the notes on the back before filling in this page) -n n n n <

552127 A7 B7 ---------------— 五、發明說明() 引起之復測。亦可進行更多次數之測量。然而以三次測量 為宜’以控制整個測量週期,然而,該週期應不超過$至 7分鐘。 依據本發明之裝置乃上述之方法,以非侵入式量測病 人之血壓。為此目的,該裝置設有一用於以示波計測量法 確定病人心臟舒張與心臟收縮壓以及搏動率之器件。 該裝置尚設有一用於存儲心臟收縮與心臟舒張壓以及 搏動率三者一系列連續測量結果之器件。該裝置包括有一 用於分析心臟舒張與心臟收縮壓以及搏動率三者該等一系 列連繼測量結果之器件。該用於分析結果之器件適於確定 :心臟舒張或心臟收縮壓之結果是否連續遞減或遞增,同 時搏動率之結果是否遞減。 依據本發明一較佳之實施例,該用於分析之器件尚適 於確定上文所謂之變量指數,並用於將該變量指數與一預 定的或可預定的變量指數極限進行比較。 依據本發明另一較佳之實施例,該用於分析之器件適 於分別確定:心臟收縮與心臟舒張壓、搏動率三者等一系 列之测量結果是否低於/高於預定的或可預定的相似性極 限’以及/或者相異性極限。 依據本發明之裝置尚設有一用於基於此一系列之測量 結果而計算平均值或者加權平均值之器件。 本發明經參照以下諸實施例以及以下附圖,將得以更 清楚地理解,其中各圖顯示: 第一圖··依據本發明方法之流程圖。 9 木紙張尺度適用中_家標準(CNS)A4規格⑵心297公楚) -----------裝 i — (請先閱讀背面之注意事項再填寫本頁) 訂· 552127 A7 五、發明說明() 第二a至第二c圖:靜心狀態檢測曲線圖。 第三圖:相似性/相異性檢測曲線圖。 依據本發明,為量測出血壓,需相繼進行多次量測。 原則上是進行三次,而在某些狀況下甚至高達五次測量始 可獲致心臟舒張壓D、心臟收縮壓S,以及搏動率p。每次 測量持續約60秒。於前後兩次測量期間,另作45—6〇秒之 停頓。此項之所以必要,是因為在兩次測量之間必須讓靜 脈内完全恢復流動。依據醫學上之實際發現,此舉最少需 要45秒之時間。 該三次測量產生一系列測量結果:表示心臟舒張壓值 之Dl ’ D2,D3 ;表示心臟收縮壓值之S1,S2,S3 ;以及表 示搏動率之PI,P2,P3。這些值儲存於血壓測量裝置内。 在三次成功的測量後,可計算出平均值(見下文)並 對測量結果進行分析。 第一步,確認該病人是否處於適時的靜心狀態。為此 ,確認如下之第一條件i·)是否成立: 對於條件i ·),心臟收縮壓標準為: S3<S2 — aS<Si — 2dS , 、 (A) 式中dS約設定為5mmHg 對於條件i·),心臟舒張壓標準為: D3>D2 + dD>Dl + 2dD 或者 (β1) D3<D2-dD<Dl- 2dD , 、 (B2) 式中dD設定為約3[mmHg] 對於條件i·),搏動率標準為·· (請先閱讀背面之注意事項再填寫本頁)552127 A7 B7 ---------------— V. Description of the invention () Retest caused by. You can also make more measurements. However, it is advisable to use three measurements' to control the entire measurement cycle, however, the cycle should not exceed $ to 7 minutes. The device according to the invention is the method described above, which measures the blood pressure of a patient non-invasively. For this purpose, the device is provided with a device for determining the patient's diastolic and systolic blood pressure and pulsatile rate by oscillometric measurement. The device is also provided with a device for storing a series of continuous measurements of systolic, diastolic blood pressure, and pulsatile rate. The device includes a device for analyzing a series of successive measurements of diastolic and systolic blood pressure and pulsatile rate. The device for analyzing results is suitable for determining whether the result of diastolic or systolic blood pressure continuously decreases or increases, and whether the result of pulsation rate decreases at the same time. According to a preferred embodiment of the present invention, the device for analysis is also suitable for determining the so-called variable index and used to compare the variable index with a predetermined or predeterminable variable index limit. According to another preferred embodiment of the present invention, the device for analysis is suitable for determining whether a series of measurement results such as systolic, diastolic blood pressure, and pulsation rate are lower / higher than a predetermined or predeterminable Similarity limit 'and / or dissimilarity limit. The device according to the present invention is further provided with a device for calculating an average value or a weighted average value based on the series of measurement results. The present invention will be more clearly understood by referring to the following embodiments and the following drawings, in which each figure shows: First diagram · Flow chart of the method according to the present invention. 9 Wood Paper Standard Applicable _Home Standard (CNS) A4 Specification 297 Hearts) ----------- install i — (Please read the precautions on the back before filling this page) Order · 552127 A7 V. Description of the invention () Second a to second c: meditation state detection curve. Third figure: Similarity / dissimilarity detection curve. According to the present invention, in order to measure blood pressure, multiple measurements need to be performed successively. In principle, it is performed three times, and in some cases even up to five measurements can be made to obtain diastolic blood pressure D, systolic blood pressure S, and pulse rate p. Each measurement lasts about 60 seconds. During the two measurements before and after, another 45-60 seconds pause. This is necessary because the vein must be fully restored to flow between measurements. According to medical findings, this will take at least 45 seconds. The three measurements yield a series of measurements: Dl 'D2, D3 representing the diastolic blood pressure value; S1, S2, S3 representing the systolic blood pressure value; and PI, P2, P3 representing the pulsatile rate. These values are stored in the blood pressure measuring device. After three successful measurements, the average value can be calculated (see below) and the measurement results can be analyzed. The first step is to confirm that the patient is in a timely state of meditation. To this end, confirm whether the following first condition i ·) holds: For condition i ·), the systolic blood pressure standard is: S3 < S2 — aS < Si — 2dS, (A) where dS is set to about 5mmHg. For the condition i ·), the diastolic blood pressure standard is: D3 > D2 + dD > Dl + 2dD or (β1) D3 < D2-dD < Dl- 2dD, (B2) where dD is set to about 3 [mmHg] for condition i ·), The beat rate standard is ·· (Please read the precautions on the back before filling this page)

3030

552127 A7 (C) 五、發明說明( P3<P2 — dP2 且 p2<pi —dPl 式中dPl設定為約5[Bpm](每分鐘跳動數),而dP2 約為3[Bpm]。當病人未處於靜心狀態時,搏動率之變化會 隨時間漸減。為此原因,dPl設定成高於dP2。 若心臟收縮壓標準(A),心臟舒張壓標準(B1)或(B2)中 任一者,以及搏動率標準(C)同時成立,病人被測定為未 處於適時的放鬆狀態。 在處於未充分放鬆之狀態下,心臟收縮壓、心臟舒張 壓以及搏動率之表現示意性地顯示於第二a至第二c圖中 〇 依據第二a圖,心臟收縮壓值自第一次至第三次測量 結果持續下降。相繼的血壓值S1與S2,以及% 、S3之 間差值高於參數dS之預設極限。 第二b圖顯示若病人未適時地放鬆至靜心狀態時心臟 舒張壓之表現。於此種情形下,隨著三次測量,心臟舒張 壓通常朝一穩態值穩步遞增。依據第二b圖,數值di、的 及D3穩步遞增。D2與D1之間,以及D3、D2之間差值均 高於變數dD之預定極限。 於某些情形下,未適時放鬆之病人,其心臟舒張壓值 會朝一穩態值D3氺遞減。於此情形下,D1 *高於卯氺, 而後者則南於D3氺。 兩種狀況可見於未適時放鬆之者。 第二C圖顯示依然未適時靜心之病人其搏動率之變化 11 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----------------- (請先閲讀背面之注意事項再填寫本頁) 1J . ->*0 -線 552127 297公釐) A7 五、發明說明( 忒等搏動率值朝一穩態值遞減。相繼的測量結果ρι、 P2以及P2、P3之間差值為高於預定極限dp。 若第二a圖或第中所示之狀況成立,且第二。圖 中所示之狀況成立,則可得出結論:病人未適時地放鬆。 違病人/使用者被告知此情況,且被建議於有目的地 處於靜心狀態後再行一次測量步驟。 於又一步驟中,藉由條件ii·)確認測量結果是否顯露 血壓穩定性畸變之跡象。為此目的,依下式將一變量指數 轭行於心臟舒張、心臟收縮壓以及搏動率: ^ _ 1V1 ~ mean | n mean 其中mean =坌么 Μ η 而式中Ri为別為測量之結果Di、D2、D3,與SI、S2 S3 ’以及pi、P2、P3。該變量指數VI描述的是測量序 列中兩兩結果之標準差,且此獨立於測量之次數。 例如,若假設心臟收縮壓值為sl = 112_Hg,S2 = 124mmHg,而且S3=124mmHg,則平均值計算如下:552127 A7 (C) 5. Description of the invention (P3 < P2-dP2 and p2 < pi-dPl where dPl is set to about 5 [Bpm] (beats per minute) and dP2 is about 3 [Bpm]. When the patient is not When in a meditation state, the change in pulsation rate will gradually decrease with time. For this reason, dPl is set higher than dP2. If any of the systolic blood pressure standard (A), diastolic blood pressure standard (B1) or (B2), And the pulsatility rate standard (C) was established at the same time, and the patient was determined not to be in a timely state of relaxation. In the state of insufficient relaxation, the performance of systolic blood pressure, diastolic blood pressure, and pulsation rate are shown schematically in the second a From the second graph to the second c. According to the second graph from the second a, the systolic blood pressure value continues to decrease from the first to the third measurement results. The successive blood pressure values S1 and S2, and the difference between% and S3 are higher than the parameter dS. Figure 2b shows the performance of diastolic blood pressure if the patient does not relax to the meditation state in a timely manner. In this case, with three measurements, the diastolic blood pressure usually increases steadily toward a steady-state value. Figure b, the values of di, and D3 increase steadily The differences between D2 and D1, and between D3 and D2 are higher than the predetermined limit of the variable dD. In some cases, patients who do not relax in time, their diastolic blood pressure values will decrease towards a steady-state value D3 氺. In this case, D1 * is higher than 卯 氺, and the latter is south of D3 氺. Two conditions can be seen in those who are not relaxed in time. The second C chart shows the change in pulse rate of patients who are still not in time for meditation 11 paper scale Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----------------- (Please read the precautions on the back before filling this page) 1J.-≫ * 0-line 552127 297 mm) A7 V. Description of the invention (忒 The pulse rate value decreases toward a steady state value. Successive measurement results ρ, P2 and P2, P3 are higher than the predetermined limit dp. If The condition shown in the second a or the figure is true, and the second. The condition shown in the figure is true, it can be concluded that the patient did not relax in a timely manner. The offending patient / user was informed of this situation and was suggested After the purposeful meditation, perform the measurement step again. In another step, confirm the measurement by condition ii ·) Whether the results showed signs of distortion in blood pressure stability. For this purpose, a variable exponential yoke is applied to the diastolic, systolic blood pressure, and pulsation rate according to the following formula: ^ _ 1V1 ~ mean | n mean where mean = 坌 ΜΜ η and Ri is the measurement result Di , D2, D3, and SI, S2 S3 ', and pi, P2, P3. The Variable Index VI describes the standard deviation of the pairwise results in the measurement sequence and is independent of the number of measurements. For example, if the systolic blood pressure values are sl = 112_Hg, S2 = 124mmHg, and S3 = 124mmHg, the average is calculated as follows:

Mean = (112+124+124)/3=120_Hg 於本例中,心臟收縮壓之變量指數遂計算如下:Mean = (112 + 124 + 124) / 3 = 120_Hg In this example, the variable index of systolic blood pressure is then calculated as follows:

Vis = ^(120-112+124-120+124-20)/120=16/120=4..4% 若該變量指數高於變量指數極限值,藉由顯示此情況 而告知該使用者/病人。若變量指數頻頻超過預定之極限 ,則建議使用者(手動操作)作進一步之診斷。 該等變量指數典型者如下··對於心臟收縮壓為·1〇[0/〇] 12 (CNS)A4 (21〇T? (請先閱讀背面之注音3事項再填寫本頁) ·. 552127 A7 _B7___ 五、發明說明() ,對於心臟舒張壓為.10[%],而對於搏動率為.8[%]。 (請先閱讀背面之注意事項再填寫本頁) 在計算測量結果之平均值前,先確認連續之血壓值是 否彼此相似,亦即確認下列條件iii.)是否成立: 對於心臟收縮壓,條件iii為: S1 - 18mmHg<S2<Sl + 18mmHg S2-18mmHg<S3<S2+18mmHg 對於心臟舒張壓,條件i i i為: D1 -12mmHg<D2<Dl + 12mmHg D2 - 12mmHg<D3<D2+12mmHg 若所有以上條件均成立,所得知結論為測量結果正確 。因此,計算測量結果之標準算術平均值如下: S=(Sl+S2+S3)/3 D=(Dl+D2+D3)/3 數值S與D相繼顯示於血壓測量裝置上。 _線· 上述範圍(+/-18nnnHg以及+/-12minHg)稱為相似性極 限。 今已發現,心臟收縮壓之相似性極限+/-18mmHg與心 臟舒張壓之相似性極限+/- 12mmHg,可得出足夠精確之結 果。也可使用其他相似性極限。 此外,再確認條件iv.)是否成立。檢查諸結果是否彼 此相比較而殊異。該條件iv.)界定如下: 心臟收縮壓:Vis = ^ (120-112 + 124-120 + 124-20) /120=16/120=4..4% If the variable index is higher than the variable index limit, inform the user by displaying this situation / patient. If the variable index frequently exceeds a predetermined limit, it is recommended that the user (manual operation) make further diagnosis. These variable indexes are typically as follows: · For systolic blood pressure: 10 [0 / 〇] 12 (CNS) A4 (21〇T? (Please read the note on the back 3 before filling out this page) · 552127 A7 _B7___ 5. Explanation of the invention (), for diastolic blood pressure is .10 [%], and for pulsatility rate is .8 [%]. (Please read the precautions on the back before filling this page) Calculate the average of the measurement results Before, confirm whether the continuous blood pressure values are similar to each other, that is, confirm whether the following conditions iii.) Are true: For systolic blood pressure, condition iii is: S1-18mmHg < S2 < Sl + 18mmHg S2-18mmHg < S3 < S2 + 18mmHg For diastolic blood pressure, condition iii is: D1 -12mmHg < D2 < Dl + 12mmHg D2-12mmHg < D3 < D2 + 12mmHg If all the above conditions are true, the conclusion is that the measurement result is correct. Therefore, the standard arithmetic average of the measurement results is as follows: S = (Sl + S2 + S3) / 3 D = (Dl + D2 + D3) / 3 The values S and D are displayed on the blood pressure measurement device one after the other. _Line · The above range (+/- 18nnnHg and +/- 12minHg) is called the limit of similarity. It has been found that the similarity limit of systolic blood pressure +/- 18mmHg and the similarity limit of diastolic blood pressure +/- 12mmHg can be obtained with sufficient accuracy. Other similarity limits can also be used. In addition, confirm whether condition iv.) Is satisfied. Check whether the results are different from each other. The condition iv.) Is defined as follows: systolic blood pressure:

Sl+40mmHg <S2<S1 -40mmHg S2+40_Hg <S3<S2-4〇_Hg 13 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 552127 A7 _B7___ 五、發明說明() 心臟舒張壓:Sl + 40mmHg < S2 < S1 -40mmHg S2 + 40_Hg < S3 < S2-4〇_Hg 13 This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 552127 A7 _B7___ V. Description of the invention () Diastolic blood pressure:

Dl+25mmHg<D2<Dl-25mmHg (請先閱讀背面之注意事項再填寫本頁) D2+25mmHg<D3<D2-25mmHg 若以上四條件中至少有一項滿足,結論為測量結果中 至少有一項出自誤測。 對於心臟收縮壓為+/-40mmHg,而對於心臟舒張壓為 +/-25mmHg,該範圍稱為相異性極限。人們可大膽假設:超 出相異性極限之測量值代表贗值。對這些結果不予採用。 若以上條件i v.)不成立^亦即,若所有結果並未殊異 ,而且以上之條件iii.)不成立,亦即,該等結果未彼此 充分相似,則求出一加權平均值。 在此假設,既不相似又不殊異之血壓測量結果反映的 是一贗值,或者是一嚴重的病理性血壓變異。因此,以下 式計算出加權平均值來減少這些數值之影響: S=2Sl+2S2+S3/5 式中S3為非相似值,而 D=2Dl+2D2+D3/5 式中D3為非相似值。 更一般的通式為: A1S1 + A2S2 + A3S3 A1 + A2 + A3^ B1D1 +召2D2 +丑3D3 B1 + 52 + 53 式中A1>A3 ; A2>A3若S3未相似於S1與S2,而 B1>B3 ; B2>B3若D3未相似於D1與D2。Dl + 25mmHg < D2 < Dl-25mmHg (Please read the precautions on the back before filling out this page) D2 + 25mmHg < D3 < D2-25mmHg If at least one of the above four conditions is met, it is concluded that at least one of the measurement results comes from False test. For systolic blood pressure of +/- 40mmHg and for diastolic blood pressure of +/- 25mmHg, this range is called the limit of dissimilarity. One can boldly assume that a measurement that exceeds the limit of dissimilarity represents a threshold value. These results are not used. If the above condition i v.) Does not hold ^ That is, if all the results are not different and the above condition iii.) Does not hold, that is, the results are not sufficiently similar to each other, then a weighted average is obtained. It is assumed that blood pressure measurements that are neither similar nor distinctive reflect a threshold or a severe pathological blood pressure variation. Therefore, the following formula is used to calculate the weighted average to reduce the impact of these values: S = 2Sl + 2S2 + S3 / 5 where S3 is a non-similar value and D = 2Dl + 2D2 + D3 / 5 where D3 is a non-similar value . A more general formula is: A1S1 + A2S2 + A3S3 A1 + A2 + A3 ^ B1D1 + 2D2 + Ugly 3D3 B1 + 52 + 53 where A1 >A3; A2 > A3 if S3 is not similar to S1 and S2, and B1 >B3; B2 > B3 If D3 is not similar to D1 and D2.

Al、A2、A3與Bl、B2、B3之值,分別憑經驗而定, 對於相似值(諸如S1與S2)而言設定為2,而對於非相 似值而言設定為1。研究中凡有進一步之發現,可對這些 14 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 552127 A7 五、發明說明( 因子作修正,而不致偏離本發明之範圍。 於第三圖中,圖所示為在—系列制曰# 糸列测量期間最可能產生 特殊血壓差異之原因。 曲線1代表的是測量生理性血壓差異之機率。由於生 理原因’血壓之小差異較常出現。祗要該差異處在相似性 界定之範圍内,亦即成立條件iu),可求出標準算術平均 值。-般而言’在健康的人群中凡處於靜心狀態者,其生 理性血壓差異較小。 較大的連續性血壓差異,凡超出相異性極限,亦即成 立條件iv)者,極可能緣於層值。屑值之機率示於第三圖 之曲線3。當測量結果成立條# iv.)時,經參照高的相異 性標準,不計算平均值而將該等值拒用。 若條件iii·)與iv·)無一成立,亦即,如果測量結果 高於相似性極限但低於相異性極限,差值可能緣於病理原 因或者緣於贗值。緣於病理原因之血a差異,其機率示於 第二圖中之曲線2。在此種情形下,則計算加權平均值。 ^该相似性極限,對於心臟收縮壓設定為18mmHg,而對 臟舒張壓設定為12mmHg。相異性極限對於心臟收縮壓 设定為40mmHg,而對於心臟舒張壓設定為25mmHg。 假如有一測量值被拒用,即啟動第四次測量。相同的 刀析特別是對條件i · )、i i · )、i i i.)之確認,適用於新 JL· , 、 1 、、’且測置結果。若再有一值被拒用,便不顯示出錯訊息 ’而且也不給出測量結果。若第四次測量結果並未殊異, 亦即’如果條件iv·)不成立,則如上所述計算出測量結果 (請先閱讀背面之注意事項再填寫本頁)The values of Al, A2, A3 and Bl, B2, and B3 are determined empirically, and are set to 2 for similar values (such as S1 and S2) and 1 for non-similar values. Where there are further findings in the study, the Chinese paper standard (CNS) A4 (210 X 297 mm) can be applied to these 14 paper sizes. 552127 A7 5. Description of the invention (factors are modified without departing from the scope of the invention. In the third figure, the figure shows the most likely reason for the special blood pressure difference during the measurement of the # series. The curve 1 represents the probability of measuring the physiological blood pressure difference. Due to physiological reasons, the small difference in blood pressure More often. If the difference is within the range defined by similarity, that is, the condition iu), the standard arithmetic mean can be obtained. -Generally speaking, among those who are in a state of meditation, the difference in physiological blood pressure is small. The large continuous blood pressure difference, which exceeds the limit of dissimilarity, that is, the establishment condition iv), is most likely due to the stratum value. The probability of chip value is shown in curve 3 of the third figure. When the measurement result is in Article #iv.), After referring to the high disparity standard, the average value is not calculated and the equivalent value is rejected. If neither of conditions iii ·) and iv ·) holds, that is, if the measurement result is higher than the similarity limit but lower than the dissimilarity limit, the difference may be due to a pathological cause or a threshold value. The probability of blood a difference due to pathological reasons is shown in curve 2 in the second figure. In this case, a weighted average is calculated. ^ This similarity limit is set to 18 mmHg for systolic blood pressure and 12 mmHg for diastolic blood pressure. The anisotropy limit is set to 40 mmHg for systolic blood pressure and 25 mmHg for diastolic blood pressure. If one measurement is rejected, the fourth measurement is started. The same analysis, especially the confirmation of the conditions i ·), i i ·), i i i.), Is applicable to the new JL ·, 1, 1, and ′ and the measurement results. If another value is rejected, no error message is displayed ’and no measurement result is given. If the fourth measurement result is not different, that is, if the condition iv ·) does not hold, the measurement result is calculated as described above (please read the precautions on the back before filling this page)

P 汀· .線·P Ting ·. Line ·

552127 A7 B7 五、發明說明() 並顯示之。 對平均值處理如下: 當獲致三個血壓測量結果後,須區分下列情形: 1) V1(S)V2(S)V3 => An=^(V1+V2+V3) 2) V1(NS)V2(S)V3 A.= -(VH2V2+2V3) 3) V1(HA)V2(S)V3 V2,V3; V4 4) V1(S)V2(NS)V3 =>啟動第四次測量,並檢查 5) V1(S)V2(HA)V3 VI,V2,V4 6) V1(NS)V2(NS)V3 和 a) V3(S)V1 ^ Aw=~(2Vl+V2+2V3) 和 b) V3(NS)V1 或者 V3(HA)V1 二顯示出錯 7) V1(HA)V2(NS)V3 和 a) V3(S)V1 啟動第四次測量, 二 Aw=会(2V1+2V2+V3) =>啟動第四次測量,並檢查 並檢查VI,V3, (請先閱讀背面之注意事項再填寫本頁) •線 V4 和 b) V3(NS)V1 或者 V3(HA)V1 1顯示出錯 16 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 552127 A7 _B7__ 五、發明說明() 8) Vi(NS)V2(NA) V3 和 (請先閱讀背面之注意事項再填寫本頁) a) V3(S)V1 3啟動第四次測量,並檢查VI,V3, V4 和 b) V3(NS)V1 或者 V3(HA)V1 二顯示出錯 9) V1(HA)V2(HA)V3 和 a) V3(S)V1 二啟動第四次測量,並檢查VI,V3, V4 和 b) V3(NS)V1 或者 V3(HA)V1 二顯示出錯 式中 —VI、V2、V3、V4表示心臟收縮或心臟舒張壓。 一(S)表示相繼測得之值相似 一 (NS)表示相繼測得之值不相似 一 (HA)表示相繼測得之值殊異 本發明之方法更詳細地顯示於第一圖之流程圖中。 第一圖顯示本發明一實施例之流程圖。血壓測量裝置 可在單次模式或者平均值模式下操作。於單次模式下操作 時,變量平均化計數值設定為1。於平均值模式下操作時 ,變量平均化計數值設定成預定之測量次數,諸如3。若 17 木紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 552127 A7 -------—__B7__ 五、發明說明() 該裝置在平均值模式下操作,測量重覆多次,例如三次, 對心臟收縮與心臟舒張壓,以及搏動頻率各產生三個相連 繼之數值結果。倘若已獲致三個相連繼之心臟收縮與心臟 收縮壓結果,檢查這些數值之相似性與相異程度。若檢查 出所有三個數值之相似性,即形成常規之平均值(見第一 圖之左側分支)。 若第二次結果與第一及第三次均不相似,則檢查第一 與第二次之結果是否彼此相似。若第一次與第三次之結果 相似’再進行一次測量;不然會顯示出錯。若再行一次測 量,將變量“meanflag”設定為1。若該變量meanflag原 先已設定為1,顯示出錯訊息。此舉意味著在數值不相似 之情形下,抵可能出現有限次數,諸如一次之重覆。 若第二次結果與第一及第三次均不相似,確認第一或 第三次之結果是否與第二次之值殊異。若未殊異,啟動覆 測程序,以獲致又一次測量結果。若計劃進行又一次測量 ,先檢查變量meanflag。若該變量meanflag原先已設定 為1 ’則不予再行測量並顯示出錯訊息。 j計算常規平均值或者加權平均值之後,以及顯示結 果之前,進行下列程序·· 基於測量值,確認病人是否適時地放鬆。若發現該病 未i夺地放氣、,則顯示未放鬆標記,並於再次進行測量 之别,要求病人適時地放鬆。 此外’基於測量值而形成變量指數。若變量指數νι 高於變量指數極限vlLiBit,則顯示出錯訊束。 (請先閱讀背面之注意事項再填寫本頁)552127 A7 B7 V. Description of the invention () and display it. The average value is processed as follows: When three blood pressure measurement results are obtained, the following situations must be distinguished: 1) V1 (S) V2 (S) V3 = > An = ^ (V1 + V2 + V3) 2) V1 (NS) V2 (S) V3 A. =-(VH2V2 + 2V3) 3) V1 (HA) V2 (S) V3 V2, V3; V4 4) V1 (S) V2 (NS) V3 = > Start the fourth measurement, And check 5) V1 (S) V2 (HA) V3 VI, V2, V4 6) V1 (NS) V2 (NS) V3 and a) V3 (S) V1 ^ Aw = ~ (2Vl + V2 + 2V3) and b ) V3 (NS) V1 or V3 (HA) V1 Second display error 7) V1 (HA) V2 (NS) V3 and a) V3 (S) V1 Start the fourth measurement, Aw = Yes (2V1 + 2V2 + V3 ) = > Start the fourth measurement, and check and check VI, V3, (Please read the precautions on the back before filling this page) • Line V4 and b) V3 (NS) V1 or V3 (HA) V1 1 display Error 16 This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 552127 A7 _B7__ V. Description of the invention () 8) Vi (NS) V2 (NA) V3 and (Please read the precautions on the back first Fill in this page again) a) V3 (S) V1 3 Start the fourth measurement and check VI, V3, V4 and b) V3 (NS) V1 or V3 (HA) V1 Second display error 9) V1 (HA) V2 (HA) V3 and a) V3 (S) V1 Start the fourth measurement and check VI, V3, V4 and b) V3 (NS) V1 or V3 (HA) V1 two display errors where — VI, V2, V3, and V4 represent systolic or diastolic blood pressure. One (S) indicates that the successively measured values are similar. One (NS) indicates that the successively measured values are not similar. One (HA) indicates that the successively measured values are different. The method of the present invention is shown in more detail in the flowchart of the first figure. . The first figure shows a flowchart of an embodiment of the present invention. The blood pressure measuring device can be operated in single or average mode. When operating in single mode, the variable average count value is set to 1. When operating in the average mode, the variable average count value is set to a predetermined number of measurements, such as 3. If 17 wood paper size is applicable to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 552127 A7 ----------- __B7__ V. Description of the invention () The device operates in average mode and repeats the measurement Multiple times, such as three times, produce three consecutive numerical results for each of the systolic and diastolic blood pressure, and the beat frequency. If three consecutive systolic and systolic blood pressure results have been obtained, check the similarity and dissimilarity of these values. If the similarity of all three values is checked, a normal average is formed (see the left branch of the first figure). If the second result is not similar to the first and third results, check whether the first and second results are similar to each other. If the results of the first and third times are similar ’, take another measurement; otherwise, an error will be displayed. To perform the measurement again, set the variable "meanflag" to 1. If the variable meanflag was previously set to 1, an error message is displayed. This means that in cases where the values are not similar, the offset may occur a limited number of times, such as one repetition. If the second result is not similar to the first and third results, confirm whether the first or third result is different from the second value. If it is not different, start the review process to obtain another measurement result. If you plan to take another measurement, first check the variable meanflag. If the variable meanflag was originally set to 1 ', no further measurement will be performed and an error message will be displayed. j After calculating the normal or weighted average, and before displaying the results, perform the following procedure ... Based on the measured values, confirm that the patient is relaxed in a timely manner. If the disease is not deflated, a non-relaxation mark is displayed, and the patient is required to relax in time before taking another measurement. In addition, a variable index is formed based on the measured value. If the variable index νι is higher than the variable index limit vlLiBit, an error beam is displayed. (Please read the notes on the back before filling this page)

18 552127 A7 _B7___五、發明說明()換言之··於計算出平均值後,應確認以上所謂之條件 i)或者條件ii)是否成立。若是,則會顯示出合理的標記 (請先閱讀背面之注意事項再填寫本頁) tal·. •線 木紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)18 552127 A7 _B7___ V. Description of the invention () In other words, after calculating the average value, you should confirm whether the above-mentioned condition i) or condition ii) is true. If it is, a reasonable mark will be displayed (please read the precautions on the back before filling this page) tal ·. • The size of the wood paper is applicable to China National Standard (CNS) A4 (210 X 297 mm)

Claims (1)

552127 A8552127 A8 種以非知入式測量病人血壓之方法,包含有步 驟有: / a測里该病人之心臟舒張與心臟收縮壓值,且最权 是藉助示波計; b )重覆步驟a )至少一次,藉此產生心臟收縮與 張收縮壓以及搏動率之一系列相繼的測量結果⑸,幻, S3,Dl,D2,D3,Pl,P2,P3 ); c )藉由確認第一條件(i)是否成立,自動分析該等 一系列相繼之結果來確定該等結果之有效性,倘若心臟收 縮壓之測里結果連續遞減,心臟舒張壓之測量結果連續遞 減或遞增,而搏動率之測量結果連續遞減,則該第一條件 (i.)成立。 2 ·如申請專利範圍第1項所述之方法,其中於步驟 c )中’依據下列公式計算出心臟舒張壓、心臟收縮壓以 及搏動率之變量指數(VI): yj = 1今 1 Rj ~ mean | | Λ. - mean | η μ mean h i=l 其中mean = 和 m n 式中Ri分別為測量結果0)1,D2,D3,Sl,S2,& Pl,P2,P3),而且 式中n為測量心臟舒張壓、心臟收縮壓以及搏動率中 每一系統結果之次數,並且 藉此確認第二條件(ii·)是否成立,倘若變量指數(VI) 高於對心臟舒張壓、心臟收縮壓以及搏動率三參數中至少 20 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) r>靖先閱讀背面之注意事項再場寫本頁) 訂 、申請專利範圍 立 者所預定之變量指量極限(vw),則第二條件(ii)成 3 ·如中請補第丨項所述之方法, 驟尚有: 確認第三條件(iii.)是否成立,其中當測量心臟收縮 與心臟舒張壓,相繼的測量結果間之差值小於一預定的或 可預定的相似性極限時’該第三條件(出.)成立,以及 破認第四條件(iv.)是否成立,其中當測量心臟收縮 與心臟舒張壓,相繼的測量結果間之差值大於一預定的或 可預定的相異性極限時,該第四條件(iv )成立。 4 ·如申請專利範圍第2項所述之方法,其包含之步 驟尚有· 確認第三條件(iii.)是否成立,其中當測量心臟收縮 與心臟舒張壓’相繼的測量結果間之差值小於一預定的或 可預定的相似性極限時,該第三條件(iii )成立,以及 確認第四條件(iv.)是否成立,其中當測量心臟收縮 與心臟舒張壓,相繼的測量結果間之差值大於一預定的或 可預定的相異性極限時,該第四條件(iv )成立。 5 ·如申請專利範圍第1項所述之方法,其中倘若該 第一條件(i ·)成立,則 一產生一訊號,建議使用者重覆進行測量,或者 —於一段預定之時間後,自動啟動一次附加測量,以 及/或者 —產生一訊號,該訊號指出:於測量過程中使用者未 552127 C8 ----^__ > --—------------- A、申請專利範圍 適時地放鬆至靜心狀態。 6 ·如申請專利範圍第2項所述之方法,其中倘若該 第一條件(i·)成立,則 一產生一訊號,建議使用者重覆進行測量,或者 一於一段預定之時間後,自動啟動一次附加測量,以 及/或者 一產生一訊號,該訊號指出:於測量過程中使用者未 適時地放鬆至靜心狀態。 7 ·如申請專利範圍第3項所述之方法,其中倘若該 第一條件(i.)成立,則 一產生一訊號,建議使用者重覆進行測量,或者 一於一段預定之時間後’自動啟動一次附加測量,以 及/或者 一產生一訊號,該訊號指出:於測量過程中使用者未 適時地放鬆至靜心狀態。 8 ·如申請專利範圍第4項所述之方法,其中倘若該 第一條件(i·)成立,則 一產生一訊號,建議使用者重覆進行測量,或者 一於一段預定之時間後,自動啟動一次附加測量,以 及/或者 一產生一訊號,該訊號指出:於測量過程中使用者未 適時地放鬆至靜 心狀態。 9 ·如申請專利範圍第2項所述之方法,其中偏若該 第二條件(ii·)成立,便會顯示出一訊息。 ........................— (請先閲讀背面之注意事項再塡寫本頁) 、一r 口 22 552127 、申請專利範圍 :U ·如申請專利範圍第3項所述之方法,其中倘若 該第一條件(111·)成立,便對心臟舒張壓(D1,D2,D3)與心 臟收,壓(SI,S2, S3)以及搏動率(P1,P2, p3)三者之測量結 果計算出算術平均值,並顯示之,而且 倘若第四條件(iv)成立,對大於相異性極限之結果予 以省略,並對心臟收縮與心臟舒張壓進行一次新的測量, 以及 倘若該第三條件(iii.)不成立,則對心臟舒張壓測量 結果以及搏動頻率結果計算出加權平均值。 1 1 · 一種以非侵入式測量病人血壓,特別是用於實 施上述申請專利範圍第丄至丄〇項中任一項方法之裝置, 該裝置包含有: 以 一用於以非侵入式測量病人心臟收縮與心臟舒張壓 及搏動率之器件; 者 (請先閲讀背面之注意事項再塡寫本頁) —用於存儲心臟收縮壓、心臟舒張壓以及搏動率三 一系列連續測量結果之器件; —用於分析心臟收縮壓、心臟舒張壓以及搏動率三者 一系列連繼測量結果之器件; 其中該分析之器件乃為確認心臟收縮壓之結果是否連 續遞減,心臟舒張收縮壓之結果是否連續遞增或遞減,以 及搏動率之結果是否連續遞減。 1 2 ·如申請專利範圍第1 1項所述之裝置,其中分 析之器件適於依據下列公式,計算出心臟舒張壓、心臟收 縮壓以及搏動率中每一者之變量指數(VI): 23 552127 A8 B8 C8 D8 六 申請專利範園 VI η η Σ 丨尽一 mean mean mean = — Vi?/ n /si 而 測 其中为析之器件是為確認該變量指數是否大於一預定 的或可預定的變量指數極限。 13·如申請專利範圍第11項所述之裝置,其中分 析之器件是為確認:心臟收縮壓與心臟舒張壓中相繼的測 量結果間之差值是否大於一預定的或可預定的相異性極限 ’或者小於一預定的或可預定的相似性極限。 1 4 ·如申請專利範圍第1 2項所述之裝置,其中分 析之器件是為確認:心臟收縮壓與心臟舒張壓中相繼的測 量結果間之差值是否大於一預定的或可預定的相異性極限 ’或者小於一預定的或可預定的相似性極限。 1 5 ·如申請專利範圍第1 1項所述之裝置,其中該 裝置尚包含有一對心臟收縮壓與心臟舒張壓之測量結果而 求出平均值之器件,以及對心臟收縮壓與心臟舒張壓之測 量結果而求出加權平均值之器件。 1 6 ·如申請專利範圍第1 2項所述之裝置,其中該 裝置尚包含有一對心臟收縮壓與心臟舒張壓之測量結果而 f出平均值之器件,以及對心臟收縮壓與心臟舒張壓之測 1結果而求出加權平均值之器件。 1 7 ·如申請專利範圍第1 3項所述之裝置,其中該 裝置尚包含有一對心臟收縮壓與心臟舒張壓之測量結果 f出平均值之器件,以及對心臟收縮壓與心臟舒張壓之 I結果而求出加權平均值之器件。 1 8 ·如申請專利範圍第1 4項所述之裝置,其中該 ⑽ x 297 公幻_ (請先閲讀背面之注意事項再填寫本頁) 訂-· 線 552127 A8 B8 C8 D8 六、申請專利範圍 裝置尚包含有一對心臟收縮壓與心臟舒張壓之測量結果而 求出平均值之器件,以及對心臟收縮壓與心臟舒張壓之測 量結果而求出加權平均值之器件。 (請先閲讀背面之注意事項再填寫本頁) 線 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)A non-intrusive method for measuring a patient's blood pressure, including the steps of: / a measuring the patient's diastolic and systolic blood pressure values, and the best weight is with an oscilloscope; b) repeat step a) at least once , Thereby generating a series of successive measurement results of cardiac systolic and systolic blood pressure and pulsation rate ⑸, phantom, S3, D1, D2, D3, Pl, P2, P3); c) by confirming the first condition (i) Whether it is true, the series of successive results are automatically analyzed to determine the validity of the results. If the results of the systolic blood pressure continuously decrease, the measurement of the diastolic blood pressure continuously decreases or increases, and the measurement of the pulse rate continues. Decreasing, then the first condition (i.) Holds. 2 · The method according to item 1 of the scope of patent application, wherein in step c), the variable index (VI) of diastolic blood pressure, systolic blood pressure and pulsatility rate is calculated according to the following formula: yj = 1 to 1 Rj ~ mean | | Λ.-mean | η μ mean hi = l where mean = and mn where Ri is the measurement result 0) 1, D2, D3, Sl, S2, & Pl, P2, P3), and in the formula n is the number of measurements of each system result in diastolic blood pressure, systolic blood pressure, and pulsation rate, and is used to confirm whether the second condition (ii ·) holds, provided that the variable index (VI) is higher than the diastolic blood pressure, systole At least 20 of the three parameters of pressure and pulsation rate are in accordance with the Chinese National Standard (CNS) A4 specification (210 X 297 mm) r > Jing first read the precautions on the back and write this page) The predetermined variable refers to the quantity limit (vw), then the second condition (ii) becomes 3 · As mentioned in the above, please supplement the method described in item 丨, and there are still: Confirm whether the third condition (iii.) Holds, where Measure systolic and diastolic blood pressure, successively measure results When the difference is less than a predetermined or predeterminable similarity limit, the third condition (out.) Is established, and whether the fourth condition (iv.) Is established, wherein when measuring systolic and diastolic blood pressure, The fourth condition (iv) holds when the difference between successive measurement results is greater than a predetermined or predeterminable dissimilarity limit. 4 · The method as described in item 2 of the scope of patent application, which includes the remaining steps. · Confirm whether the third condition (iii.) Is established, wherein when measuring the difference between the systolic and diastolic blood pressure 'successive measurements When it is less than a predetermined or predeterminable similarity limit, the third condition (iii) is established, and whether the fourth condition (iv.) Is established, wherein when measuring systolic and diastolic blood pressure, successive measurement results are in between When the difference is greater than a predetermined or predeterminable dissimilarity limit, the fourth condition (iv) is satisfied. 5 · The method described in item 1 of the scope of patent application, wherein if the first condition (i ·) is satisfied, a signal is generated and the user is recommended to repeat the measurement, or-after a predetermined period of time, automatically Start an additional measurement, and / or—generate a signal that indicates that the user did not 552127 C8 during the measurement ---- ^ __ > --------------- A. The scope of patent application is to relax to meditation in a timely manner. 6 · The method as described in item 2 of the scope of patent application, wherein if the first condition (i ·) is satisfied, a signal is generated and the user is recommended to repeat the measurement, or automatically after a predetermined period of time An additional measurement is initiated, and / or a signal is generated, which indicates that the user did not relax to a meditation state in a timely manner during the measurement. 7 · The method as described in item 3 of the scope of patent application, wherein if the first condition (i.) Is satisfied, a signal is generated and the user is recommended to repeat the measurement, or after a predetermined period of time 'automatic An additional measurement is initiated, and / or a signal is generated, which indicates that the user did not relax to a meditation state in a timely manner during the measurement. 8 · The method as described in item 4 of the scope of patent application, wherein if the first condition (i ·) is satisfied, a signal is generated and the user is advised to repeat the measurement, or automatically after a predetermined period of time An additional measurement is initiated, and / or a signal is generated, which indicates that the user did not relax to a meditation state in a timely manner during the measurement. 9 · The method described in item 2 of the scope of patent application, wherein if the second condition (ii ·) is satisfied, a message is displayed. ..............- (Please read the notes on the back before writing this page), a port 22 552127, the scope of patent application: U · The method as described in item 3 of the scope of patent application, wherein if the first condition (111 ·) is satisfied, the diastolic blood pressure (D1, D2, D3) and the cardiac pressure (SI, S2, S3) And the pulsation rate (P1, P2, p3). The arithmetic mean is calculated and displayed, and if the fourth condition (iv) is true, the results greater than the limit of dissimilarity are omitted, and the contraction of the heart and the A new measurement of the diastolic blood pressure is performed, and if the third condition (iii.) Is not satisfied, a weighted average is calculated for the diastolic blood pressure measurement result and the pulsation frequency result. 1 1 · A device for non-invasively measuring a patient's blood pressure, in particular for implementing the method of any one of items 丄 to 丄 0 of the above-mentioned patent application, the device comprising: a device for non-invasively measuring a patient's blood pressure Devices for systolic and diastolic blood pressure and pulsatile rate; (Please read the precautions on the back before writing this page)-devices used to store three series of continuous measurement results of systolic blood pressure, diastolic blood pressure and pulsatile rate; —A device used to analyze a series of consecutive measurement results of systolic blood pressure, diastolic blood pressure, and pulsatile rate; the analysis device is to confirm whether the result of systolic blood pressure is continuously decreasing and whether the result of diastolic blood pressure is continuous. Increasing or decreasing, and whether the result of the pulsation rate is continuously decreasing. 1 2 · The device according to item 11 of the scope of patent application, wherein the analyzed device is adapted to calculate a variable index (VI) of each of diastolic blood pressure, systolic blood pressure and pulsation rate according to the following formula: 23 552127 A8 B8 C8 D8 VI Patent Application Park VI η η Σ 丨 Mean mean mean = — Vi? / N / si The measured device is to confirm whether the variable index is greater than a predetermined or predeterminable Variable exponential limit. 13. The device as described in item 11 of the scope of patent application, wherein the analyzed device is to confirm whether the difference between successive measurement results of systolic blood pressure and diastolic blood pressure is greater than a predetermined or predefinable dissimilarity limit 'Or less than a predetermined or predeterminable similarity limit. 1 4 · The device as described in item 12 of the scope of patent application, wherein the analyzed device is to confirm whether the difference between successive measurement results of systolic blood pressure and diastolic blood pressure is greater than a predetermined or predeterminable phase Heterosexual limit 'or less than a predetermined or predefinable similarity limit. 15 · The device according to item 11 of the scope of the patent application, wherein the device further comprises a device for obtaining an average of a pair of measurement results of systolic blood pressure and diastolic blood pressure, and a device for systolic blood pressure and diastolic blood pressure The measurement results are used to obtain a weighted average device. 16 · The device according to item 12 of the scope of patent application, wherein the device further includes a pair of systolic pressure and diastolic blood pressure measurement results and an average value of f, and a device for systolic pressure and diastolic blood pressure A device that measures a result and obtains a weighted average. 17 · The device as described in item 13 of the scope of patent application, wherein the device further comprises a pair of means for averaging the measurement results f of systolic and diastolic blood pressure, and a device for measuring the systolic and diastolic blood pressure. The result is the device that calculates the weighted average. 1 8 · The device described in item 14 of the scope of patent application, in which the ⑽ x 297 public magic _ (Please read the notes on the back before filling this page) Order-· Line 552127 A8 B8 C8 D8 VI. Patent application The range device also includes a pair of devices that calculate the average of systolic and diastolic blood pressure measurements and a device that calculates the weighted average of the systolic and diastolic blood pressure measurements. (Please read the precautions on the back before filling this page) Thread This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)
TW91109947A 2001-05-14 2002-05-10 A device and a method for non-invasively measuring the blood pressure TW552127B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29034901P 2001-05-14 2001-05-14

Publications (1)

Publication Number Publication Date
TW552127B true TW552127B (en) 2003-09-11

Family

ID=31715441

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91109947A TW552127B (en) 2001-05-14 2002-05-10 A device and a method for non-invasively measuring the blood pressure

Country Status (1)

Country Link
TW (1) TW552127B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9113791B2 (en) 2005-08-12 2015-08-25 Omron Healthcare Co., Ltd. Electronic blood pressure monitor calculating average value of blood pressure

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9113791B2 (en) 2005-08-12 2015-08-25 Omron Healthcare Co., Ltd. Electronic blood pressure monitor calculating average value of blood pressure

Similar Documents

Publication Publication Date Title
Chung et al. Non-invasive continuous blood pressure monitoring: a review of current applications
EP1387635B1 (en) Non invasive measurement of blood pressure
TW476631B (en) A non invasive blood pressure monitor and a method for the non invasive measurement of the blood pressure
JP5689116B2 (en) Method and apparatus for detecting and evaluating reactive hyperemia using segmental plethysmography
US6719703B2 (en) Method and apparatus for measuring blood pressure by the oscillometric technique
JPH02503523A (en) Blood pressure determination device, mean arterial pressure determination device, cardiovascular status determination device, and cardiac pacemaker adjustment aid device
CN102469947B (en) Using Signal Transit Time to Monitor Cardiovascular Conditions
KR101800705B1 (en) Blood pressure monitoring apparatus and method for correcting error of blood pressure
JP4289850B2 (en) Automatic indirect non-invasive device and method for determining diastolic blood pressure by calibrating vibration waveforms
JP2012509123A (en) Blood pressure measuring device and method
US20100204588A1 (en) Method and apparatus for detecting measurement site of blood pressure
US20060224070A1 (en) System and method for non-invasive cardiovascular assessment from supra-systolic signals obtained with a wideband external pulse transducer in a blood pressure cuff
US9585573B2 (en) Apparatus and method for estimating blood pressure by using variable characteristic ratio
WO2008023950A1 (en) Blood pressure measurement apparatus
EP1659949A1 (en) Apparatus and method for early detection of cardiovascular disease using vascular imaging
US20230355182A1 (en) System and method for validating cardiovascular parameter monitors
TW552127B (en) A device and a method for non-invasively measuring the blood pressure
JPWO2005112774A1 (en) Ultrasonic diagnostic apparatus and control method of ultrasonic diagnostic apparatus
JP6494669B2 (en) Method and apparatus for detecting and evaluating reactive hyperemia using segmental plethysmography
KR20110000287A (en) Method and apparatus for measuring blood pressure by correcting errors
Sharman et al. Measurements of arterial pressure and flow in vivo
Kaliujnaya et al. The assessment of blood pressure in atrial fibrillation
Cihelka Blood Pressure: The History and Development of Monitoring Modalities
Weber HW 02-3 AMBULATORY CENTRAL BLOOD PRESSURE: WHAT IS THE EVIDENCE FOR VALIDATION?
Cihelka Evaluating Blood Pressure Methods in Non-traumatic Intracerebral Hemorrhage: A Two-site Prospective Observational Study

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees